Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection in Patients With Obesity or Diabetes: A Subgroup Analysis of Pooled Phase 3 Clinical Trials.

Todd Riccobene,John Lock, Rosie D Lyles,Benjamin Georgiades, Michael Nowak,Pedro L Gonzalez,Jenny Park,Urania Rappo

Open forum infectious diseases（2023）

引用 0|浏览2

暂无评分

摘要

Dalbavancin is effective, with sustained clinical success rates in patients with obesity or diabetes, with a similar safety profile across patient groups.

查看译文

关键词

acute bacterial skin,skin structure infection,treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要